NewGenIVF Reaches US$7.6M Market Cap After Issuing 3.7M Shares for K25.ai Deal
NIVF•NewGenIVF issued 3,666,667 new shares, bringing total outstanding to 10,073,535 and pushing market capitalization to US$7.63 million. This market cap remains below its US$25.98 million net asset value even after a US$10 million investment in K25.ai, underscoring significant upside potential ahead of Nasdaq compliance.
1. Share Issuance and Capitalization
NewGenIVF completed the issuance of 3,666,667 new shares, increasing total outstanding shares to 10,073,535 and elevating its market capitalization to US$7,631,710 as of June 18, 2026.
2. NAV Discount and Upside Potential
The US$7.63 million market cap is substantially below the company’s US$25.98 million net asset value as of December 31, 2025, indicating significant valuation upside for shareholders.
3. Strategic K25.ai Investment and Pivot
The company invested an additional US$10 million to acquire a 10% equity stake in K25.ai, marking a strategic shift toward AI-powered prediction markets, live-streaming platforms, and a digital assets treasury strategy.
4. Nasdaq Compliance and Future Outlook
With market capitalization exceeding the US$5 million Nasdaq MVLS threshold, NewGenIVF expects to maintain listing compliance while pursuing strategic partnerships, further investments, and recruitment of value-oriented shareholders.
